Navigation Links
Cancer Vaccines: From First-in-Class to Best-in-Class?
Date:4/9/2013

e Treatment of Bladder Cancer 427
Table 61: Target Strategy Development Profiles of Cancer Vaccine Drugs for the Treatment of Bone Cancer 428
Table 62: Target Strategy Development Profiles of Cancer Vaccine Drugs for the Treatment of Brain Cancer 429
Table 63: The Competition through Close Mechanistic Approximation between Brain Cancer Drugs 429
Table 64: Target Strategy Development Profiles of Cancer Vaccine Drugs for the Treatment of Breast Cancer 431
Table 65: The Competition through Close Mechanistic Approximation between Breast Cancer Drugs 432
Table 66: Target Strategy Development Profiles of Cancer Vaccine Drugs for the Treatment of Cancer (general) 434
Table 67: Target Strategy Development Profiles of Cancer Vaccine Drugs for the Treatment of Cervical Cancer 435
Table 68: The Competition through Close Mechanistic Approximation between Cervical Cancer Drugs 437
Table 69: Target Strategy Development Profiles of Cancer Vaccine Drugs for the Treatment of Cervical Dysplasia 438
Table 70: The Competition through Close Mechanistic Approximation between Cervical Dysplasia Drugs 439
Table 71: Target Strategy Development Profiles of Cancer Vaccine Drugs for the Treatment of Chronic Myelogenous Leukemia 440
Table 72: Target Strategy Development Profiles of Cancer Vaccine Drugs for the Treatment of Colorectal Adenoma 441
Table 73: Target Strategy Development Profiles of Cancer Vaccine Drugs for the Treatment of Colorectal Cancer 442
Table 74: The Competition through Close Mechanistic Approximation between Colorectal Cancer Drugs 443
Table 75: Target Strategy Development Profiles of Cancer Vaccine Drugs for the Treatment of Endometrial Cancer 445
Table 76: Target Strategy Development Profiles of Cancer Vaccine Drugs for the Treatment of Fallopian Tube Cancer 446
Table 77: Target Strategy Development Profiles of Cancer Vaccine Drugs for the Treatment of Gastrointestinal Canc
'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related medicine technology :

1. NewGen Therapeutics Presents Data on NT-113, A Novel Pan-ErbB Inhibitor, at American Association of Cancer Research
2. Exosome Presents Late-Breaking Study Demonstrating Ability to Profile RNA from Archived Clinical Trial Blood Samples at 2013 American Association of Cancer Research Annual Meeting
3. Take the Skyhook Challenge and Help Beat Blood Cancer
4. Merrimack Pharmaceuticals Preclinical Research Shows MM-121 Restores Sensitivity to Anti-Estrogen Therapy and Delays Onset of Treatment Resistance in ER-Positive Breast Cancer Model
5. Positive Preclinical Data for NKTR-214, an Investigational Cancer Immunotherapy Targeting the IL-2 Receptor Complex, Presented at AACR Annual Meeting 2013
6. Penn Medicines New Center For Personalized Diagnostics Unlocks Cancers Secrets
7. Cerulean Pharma to Present Data on CRLX101s HIF-1a Inhibition at the American Association for Cancer Research Annual Meeting
8. Merrimack Pharmaceuticals Announces Top-Line Results From A Single Arm Phase 2 Advanced Lung Cancer Study In Patients With Resistance To An Anti-EGFR Tyrosine Kinase Inhibitor
9. NewLink Genetics Presents Preclinical Data on NLG919, a New Drug Candidate from a Novel Class of IDO Pathway Inhibitors for the Treatment of Cancer
10. National Cancer Organizations Issue Joint Statement On Devastating Impact Of Sequestration
11. DelMar Pharmaceuticals to Present Clinical Data from VAL-083 Brain Cancer Trial at the American Association of Cancer Research Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... September 1, 2015 BerGenBio AS ... announces that it has appointed Hilde Furberg ... to its Board of Directors, effective immediately. ... experience in pharma and biotech and is currently Senior ... company. Previously her role was Vice President and General ...
(Date:9/1/2015)... 1, 2015  Valeant Pharmaceuticals International, Inc. (NYSE: ... that its affiliate has entered into a collaboration ... an exclusive license to develop and commercialize brodalumab. ... monoclonal antibody in development for patients with moderate-to-severe ... Valeant will hold the exclusive rights to develop ...
(Date:8/31/2015)... PHOENIX , Aug. 31, 2015  DICOM ... announced today that it was recognized as a ... Radiology software.  The awards are sponsored ... and related professionals in the medical imaging industry.  ... for radiology professionals to acknowledge the contributions of ...
Breaking Medicine Technology:BerGenBio Appoints Non-Executive Directors 2Valeant And AstraZeneca To Partner On Brodalumab 2Valeant And AstraZeneca To Partner On Brodalumab 3Valeant And AstraZeneca To Partner On Brodalumab 4DG Suite Nabs "Minnies" Nomination for "Best New Radiology Software" 2
... 2012   Syndax Pharmaceuticals, Inc. and Ventana Medical ... an agreement to develop a companion diagnostic assay to ... treatment with erlotinib and Syndax,s proprietary lead molecule entinostat.  ... Ventana, a world leader and innovator of tissue-based diagnostic ...
... (Nasdaq: VRNM ), a leading industrial biotechnology ... enzymes, today announced the introduction of VEREFLOW™ alpha-amylase, a ... drilling operations.  This high performance enzyme effectively removes filter ... on the face of the wellbore, the hole drilled ...
Cached Medicine Technology:Syndax Pharmaceuticals Signs Agreement with Ventana Medical Systems, Inc. to Develop Companion Diagnostic Test for Entinostat 2Syndax Pharmaceuticals Signs Agreement with Ventana Medical Systems, Inc. to Develop Companion Diagnostic Test for Entinostat 3Syndax Pharmaceuticals Signs Agreement with Ventana Medical Systems, Inc. to Develop Companion Diagnostic Test for Entinostat 4Verenium Launches Second Enzyme Product for Oilfield Services 2Verenium Launches Second Enzyme Product for Oilfield Services 3
(Date:9/1/2015)... ... September 01, 2015 , ... ... information about new patients directly from Practice Perfect to FOTO enabling cost and ... , Steven Presement, President of Practice Perfect, stated "FOTO is ...
(Date:9/1/2015)... ... September 01, 2015 , ... Routines… every family has them. Whether ... make things easier for parents, caregivers and children too. Here are three reasons why ... and small become more fluid. When a routine is implemented into a child’s schedule, ...
(Date:9/1/2015)... ... September 01, 2015 , ... Specialty Technical Publishers (STP) and ... Protocol Consortium (IAPC) EHS audit protocol for the European Union. Leading companies around ... EHS regulatory obligations and rapidly collect, share, archive, and export audit findings in ...
(Date:8/31/2015)... TN (PRWEB) , ... September 01, 2015 , ... The ... and other clinically relevant measures for physical therapy patients. The Registry is being developed ... of FOTO, Inc. stated "We are happy to be selected to contribute FOTO Outcomes ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... potential patients the resources they need to have a successful cosmetic procedure; from ... plastic surgeons; Cosmetic Town Journal is always ready to help. , It is ...
Breaking Medicine News(10 mins):Health News:FOTO Announces New Integration Partnership with Practice Perfect 2Health News:Back into the Swing of Things: How Family Routines Benefit Children 2Health News:Specialty Technical Publishers (STP) and Specialty Technical Consultants(STC) Publish Environmental, Health & Safety (EHS) Audit Protocol for the European Union 2Health News:Specialty Technical Publishers (STP) and Specialty Technical Consultants(STC) Publish Environmental, Health & Safety (EHS) Audit Protocol for the European Union 3Health News:Specialty Technical Publishers (STP) and Specialty Technical Consultants(STC) Publish Environmental, Health & Safety (EHS) Audit Protocol for the European Union 4Health News:FOTO Selected as Official Registry Partner with Physical Therapy Outcomes Registry 2Health News:Cosmetic Town: A One Stop Plastic Surgery Community 2
... to use personal monitors (Doppler devices) to listen to their baby,s ... in seeking help for reduced fetal movements. In this week,s ... of Obstetrics and Gynaecology at Arrowe Park Hospital, Wirral describe the ... labour ward 32 weeks into her first pregnancy with reduced fetal ...
... researchers say , THURSDAY, Aug. 20 (HealthDay News) -- New ... U.S. researchers, who said the finding may also have implications ... since 1923 that tumor cells use a lot more glucose ... takes place, and how it might be stopped to control ...
... , , MONROVIA, Calif., Aug. ... developer, manufacturer and marketer of minimally invasive ophthalmic products, today reported on ... Visian ICL products in Japan. , , As anticipated, ... at the end of July in Japan, at which time the STAAR ...
... ... a nonpartisan national poll commissioned by the American Society of Medical Doctors (ASMD) that shows ... Bonati announced the poll results at a press conference earlier today in Washington, DC. ... Hudson, FL (PRWEB) August 20, ...
... ... on Lyme Disease chronicling the illness of author Lori Hall-Steele. During the documentary,s ... disease,s roots to the US Government,s Bio-warfare Program. This film uncovers conspiracy, corruption ... ...
... CONCERNS HAVE GROWN ABOUT PERCEIVED NEGATIVE EFFECTS OF REFORM, ... SENIORS REPORT THEY ARE CONFUSED ABOUT REFORM , ... slim majority of Americans continues to favor moving forward on health ... climate of contentious town hall meetings that coincide with rising concerns ...
Cached Medicine News:Health News:STAAR Surgical Reports Progress on Japanese Application for Approval of Visian(TM) Implantable Collamer(R) Lens (ICL(TM)) 2Health News:STAAR Surgical Reports Progress on Japanese Application for Approval of Visian(TM) Implantable Collamer(R) Lens (ICL(TM)) 3Health News:STAAR Surgical Reports Progress on Japanese Application for Approval of Visian(TM) Implantable Collamer(R) Lens (ICL(TM)) 4Health News:Florida Spine Surgeon Alfred Bonati, M.D. Announces Results of National Poll Showing America's Doctors Oppose a Government-Run Health Care Plan 2Health News:New Shocking Documentary on Lyme Disease 'Under the Eightball' to Premiere at Michael Moore's State Theater in Traverse City, Michigan 2Health News:Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 2Health News:Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 3Health News:Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 4Health News:Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 5Health News:Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 6
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: